1. Future trials of endovascular mechanical recanalisation therapy in acute ischemic stroke patients: a position paper endorsed by ESMINT and ESNR
- Author
-
Christophe Cognard, Mario Muto, Søren Jacob Bakke, Philip White, Jan Gralla, Michael Söderman, Jens Fiehler, Salvatore Mangiafico, Ruediger von Kummer, and Francis Turjman
- Subjects
medicine.medical_specialty ,Technology Assessment, Biomedical ,medicine.medical_treatment ,Neuroimaging ,Radiography, Interventional ,Brain Ischemia ,law.invention ,Randomized controlled trial ,law ,Humans ,Medicine ,Radiology, Nuclear Medicine and imaging ,Intensive care medicine ,Stroke ,Acute ischemic stroke ,Societies, Medical ,Interventional neuroradiology ,Thrombectomy ,Neuroradiology ,Clinical Trials as Topic ,business.industry ,Thrombolysis ,medicine.disease ,Europe ,Research Design ,Physical therapy ,Position paper ,Stents ,Research questions ,Neurology (clinical) ,Intracranial Thrombosis ,Cardiology and Cardiovascular Medicine ,business ,Forecasting - Abstract
A new era of stroke treatment may have begun with mechanical thrombectomy (MT) by fully deployed closed-cell self-expanding stents (stent-triever). Multiple case series and the first randomised controlled trials (RCTs) have now been published. More studies are under way involving large numbers of patients, which in turn has resulted in less strict "pragmatic" study protocols. Problems with current trials include a lack of standardisation in the conduct of the recanalisation procedure, the definition of primary endpoints such as the grade of arterial recanalisation and tissue reperfusion, and the post-surgical care provided. In Part 1 of this two part series, we outline the current situation and the major research questions.
- Published
- 2012
- Full Text
- View/download PDF